These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 30285067

  • 1. HLA-Mediated Platelet Refractoriness.
    Schmidt AE, Refaai MA, Coppage M.
    Am J Clin Pathol; 2019 Mar 01; 151(4):353-363. PubMed ID: 30285067
    [Abstract] [Full Text] [Related]

  • 2. HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience.
    Karlström C, Linjama T, Edgren G, Lauronen J, Wikman A, Höglund P.
    Transfusion; 2019 Mar 01; 59(3):945-952. PubMed ID: 30575964
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis and treatment of immunological platelet refractoriness by histocompatibility.
    Fagundes IS, Franz JM, Jobim MS, Arend A, Merzoni J, Cardone JM, Gil B, Sekine L, Jobim LF.
    Hum Immunol; 2020 May 01; 81(5):197-201. PubMed ID: 32067841
    [Abstract] [Full Text] [Related]

  • 4. Platelet transfusion refractoriness.
    Hod E, Schwartz J.
    Br J Haematol; 2008 Jul 01; 142(3):348-60. PubMed ID: 18510692
    [Abstract] [Full Text] [Related]

  • 5. Refractory response to platelet transfusion therapy.
    Eisenberg S.
    J Infus Nurs; 2010 Jul 01; 33(2):89-97. PubMed ID: 20228646
    [Abstract] [Full Text] [Related]

  • 6. An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial.
    Marsh JC, Stanworth SJ, Pankhurst LA, Kallon D, Gilbertson AZ, Pigden C, Deary AJ, Mora AS, Brown J, Laing ES, Choo LL, Hodge R, Llewelyn CA, Harding K, Sage D, Mijovic A, Mufti GJ, Navarrete CV, Brown CJ.
    Blood; 2021 Jan 21; 137(3):310-322. PubMed ID: 33475737
    [Abstract] [Full Text] [Related]

  • 7. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.
    Saris A, Pavenski K.
    Transfus Med Rev; 2020 Oct 21; 34(4):250-257. PubMed ID: 33127210
    [Abstract] [Full Text] [Related]

  • 8. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
    Hyun J, Lim YM, Park KD, Han BY, Kim YH, Han KS, Park MH.
    Korean J Lab Med; 2009 Oct 21; 29(5):481-9. PubMed ID: 19893359
    [Abstract] [Full Text] [Related]

  • 9. Determination in vivo viability of a transfused platelet product by corrected count increment and percentage platelet response.
    Thuku NW, Shikuku K, Mbugua A.
    Pan Afr Med J; 2017 Oct 21; 27():226. PubMed ID: 28979628
    [Abstract] [Full Text] [Related]

  • 10. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A, Picard C.
    Transfus Clin Biol; 2014 Nov 21; 21(4-5):193-206. PubMed ID: 25277423
    [Abstract] [Full Text] [Related]

  • 11. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L, Woodfield DG.
    N Z Med J; 1984 Oct 24; 97(766):719-21. PubMed ID: 6595558
    [Abstract] [Full Text] [Related]

  • 12. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
    Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong JC.
    J Surg Res; 2020 Nov 24; 255():99-105. PubMed ID: 32543385
    [Abstract] [Full Text] [Related]

  • 13. Management of the Platelet Refractory Patient.
    Forest SK, Hod EA.
    Hematol Oncol Clin North Am; 2016 Jun 24; 30(3):665-77. PubMed ID: 27113003
    [Abstract] [Full Text] [Related]

  • 14. Identification of platelet refractoriness in oncohematologic patients.
    Ferreira AA, Zulli R, Soares S, Castro Vd, Moraes-Souza H.
    Clinics (Sao Paulo); 2011 Jun 24; 66(1):35-40. PubMed ID: 21437433
    [Abstract] [Full Text] [Related]

  • 15. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
    Heal JM, Blumberg N, Masel D.
    Blood; 1987 Jul 24; 70(1):23-30. PubMed ID: 3474041
    [Abstract] [Full Text] [Related]

  • 16. Routine Solid Phase Multiplex Anti-HLA Antibody Tests Predict Platelet Refractoriness.
    Peña JRA, Makar RS.
    Am J Clin Pathol; 2019 Jul 05; 152(2):146-154. PubMed ID: 31065667
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Flow cytometric detection of platelet-reactive antibodies and application in platelet crossmatching.
    Köhler M, Dittmann J, Legler TJ, Lynen R, Humpe A, Riggert J, Neumeyer H, Pies A, Panzer S, Mayr WR.
    Transfusion; 1996 Mar 05; 36(3):250-5. PubMed ID: 8604511
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion.
    Ikeda H, Mitani T, Ohnuma M, Haga H, Ohtzuka S, Kato T, Nakase T, Sekiguchi S.
    Vox Sang; 1989 Mar 05; 57(3):213-7. PubMed ID: 2617957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.